As the medical device industry continues to evolve, manufacturers increasingly rely on partners who can combine precision engineering,...
Read PostNews
Stay up-to-date on the latest industry, member, & policy related news.
Share your News
MichBio members can submit news to be shared here, on our social media, and in our monthly newsletter.
The future of the SBIR/STTR programs has been a critical issue for the life sciences innovation ecosystem, as highlighted in prior biolink...
Read PostThe U.S. drug development landscape is entering a pivotal transition, as federal regulators and research funders accelerate efforts to reduce...
Read PostA new proposal from the U.S. Environmental Protection Agency (EPA) is reshaping the regulatory landscape for medical device sterilization -...
Read PostThe FDA’s recent draft guidance clarifying the scope of 3-year New Clinical Investigation (NCI) exclusivity is more than a technical update...
Read PostA bipartisan group of lawmakers has introduced new legislation aimed at tackling a foundational challenge in AI-driven drug discovery - the lack...
Read PostLos Angeles, CA - March 18, 2026 - Today, eXoZymes Inc. (NASDAQ: EXOZ) (“eXoZymes”) - a pioneer of AI-enhanced enzymes that transforms...
Read PostAfter months of uncertainty for startups and technology innovators across the country, the U.S. Senate has passed bipartisan legislation, S....
Read PostThe bipartisan House BIOtech Caucus recently announced its first-ever legislative endorsements, backing two bills aimed at strengthening U.S....
Read PostMichBio welcomed Michigan legislators, staff, and industry leaders to Lansing last week for a pair of back-to-back events highlighting the...
Read PostBOSTON (March 3, 2026) — TrialAssure, a leading technology provider advancing clinical trial transparency, disclosure, and data sharing,...
Read PostMichBio has expressed strong support for SB 704, legislation that would establish a State Reference Laboratory to strengthen oversight,...
Read Post